Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27339116

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Aug
First author
Incrocci L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Aug;17(8):1020-1022. doi: 10.1016/S1470-2045(16)30150-4.
    note
    Source null
    related pmid
    27339117
    relationship
    Comment in

Authors and identifiers

  1. name
    Incrocci L
    type
    Author
  2. name
    Wortel RC
    type
    Author
  3. name
    Alemayehu WG
    type
    Author
  4. name
    Aluwini S
    type
    Author
  5. name
    Schimmel E
    type
    Author
  6. name
    Krol S
    type
    Author
  7. name
    van der Toorn PP
    type
    Author
  8. name
    Jager H
    type
    Author
  9. name
    Heemsbergen W
    type
    Author
  10. name
    Heijmen B
    type
    Author
  11. name
    Pos F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Incrocci L
    type
    Author
  2. name
    Wortel RC
    type
    Author
  3. name
    Alemayehu WG
    type
    Author
  4. name
    Aluwini S
    type
    Author
  5. name
    Schimmel E
    type
    Author
  6. name
    Krol S
    type
    Author
  7. name
    van der Toorn PP
    type
    Author
  8. name
    Jager H
    type
    Author
  9. name
    Heemsbergen W
    type
    Author
  10. name
    Heijmen B
    type
    Author
  11. name
    Pos F
    type
    Author
bibliography ids
  1. nci-bib-3391e5b011f06c2eacd52e2f
book metadata
content sha256
5c315004187293b9d761fb2d85d8a808b1065ee8e2df64979a0e291a57c8fd96
document type
citation
dois
  1. 10.1016/S1470-2045(16)30070-5
electronic publication date
display
2016 Jun 20
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27339116
immutable id
pubmed:27339116@5c315004187293b9d761fb2d85d8a808b1065ee8e2df64979a0e291a57c8fd96
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
1061-1069
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Aug;17(8):1020-1022. doi: 10.1016/S1470-2045(16)30150-4.
    note
    Source null
    related pmid
    27339117
    relationship
    Comment in
outcomes validated
false
pmid
27339116
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
3af152cd2dee5af43356aec0b0e8f46f7b5f028b24465f0f683361352a522041
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Aug
precision
month
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27339116/
title
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.

Preserved source evidence · Not medical advice